Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) FCF Margin (2019 - 2025)

Silo Pharma's FCF Margin history spans 7 years, with the latest figure at 5300.93% for Q3 2025.

  • For Q3 2025, FCF Margin rose 216925.0% year-over-year to 5300.93%; the TTM value through Sep 2025 reached 6655.15%, down 134809.0%, while the annual FY2024 figure was 5317.35%, 84521.0% down from the prior year.
  • FCF Margin for Q3 2025 was 5300.93% at Silo Pharma, up from 7130.47% in the prior quarter.
  • Across five years, FCF Margin topped out at 471872.56% in Q4 2021 and bottomed at 9099.63% in Q1 2025.
  • The 5-year median for FCF Margin is 4782.45% (2022), against an average of 29628.11%.
  • The largest annual shift saw FCF Margin soared 47429629bps in 2021 before it plummeted -47678762bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 471872.56% in 2021, then crashed by -101bps to 4915.06% in 2022, then decreased by -3bps to 5048.33% in 2023, then decreased by -1bps to 5089.49% in 2024, then dropped by -4bps to 5300.93% in 2025.
  • Per Business Quant, the three most recent readings for SILO's FCF Margin are 5300.93% (Q3 2025), 7130.47% (Q2 2025), and 9099.63% (Q1 2025).